https://www.sciencedaily.com/news/health_medicine/bladder_cancer/ Bladder cancer. Read about the latest medical research on bladder cancer and related topics. en-us Mon, 20 Apr 2026 02:42:42 EDT Mon, 20 Apr 2026 02:42:42 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/bladder_cancer/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260411022031.htm Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease progression remains a major hurdle. By studying how tumors interact with and suppress the immune system, scientists aim to identify new biomarkers that reveal how the cancer evolves. Using real patient samples, the team hopes to turn earlier discoveries into practical clinical tools. The goal: more precise, personalized treatments that can outsmart even the most dangerous tumors. Sun, 12 Apr 2026 07:03:28 EDT https://www.sciencedaily.com/releases/2026/04/260411022031.htm https://www.sciencedaily.com/releases/2026/04/260405003933.htm Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can actually help tumors grow by sending signals that strengthen cancer cells. When researchers blocked this communication, tumor growth slowed dramatically in lab models. Sun, 05 Apr 2026 19:48:12 EDT https://www.sciencedaily.com/releases/2026/04/260405003933.htm https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260321012709.htm Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon tumor cells, they identified gene patterns that signal whether a cancer is likely to metastasize. Their AI model, MangroveGS, can predict this risk with about 80% accuracy and even works across multiple cancer types. This could transform how doctors decide who needs aggressive treatment and who doesn’t. Sat, 21 Mar 2026 07:44:32 EDT https://www.sciencedaily.com/releases/2026/03/260321012709.htm https://www.sciencedaily.com/releases/2026/03/260321004445.htm Scientists have engineered probiotic bacteria to act as tumor-seeking drug factories. In mice, these bacteria infiltrated tumors and produced a cancer-fighting drug right where it was needed. This targeted approach could make treatments more effective and reduce side effects. More research is needed before it can be tested in people. Sat, 21 Mar 2026 01:26:09 EDT https://www.sciencedaily.com/releases/2026/03/260321004445.htm https://www.sciencedaily.com/releases/2026/03/260319044708.htm Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and summon immune fighters deep into the tumor. These immune cells persist and attack, which was linked to longer survival in patients. Fri, 20 Mar 2026 07:59:34 EDT https://www.sciencedaily.com/releases/2026/03/260319044708.htm https://www.sciencedaily.com/releases/2026/03/260318033143.htm Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human cancers. Key mutations—like those linked to breast cancer—appear in both species, and some human cancer drugs may also work in cats. Because pets share our environments, these similarities could reveal shared causes of cancer. The research could lead to new treatments that benefit both animals and humans. Wed, 18 Mar 2026 19:12:17 EDT https://www.sciencedaily.com/releases/2026/03/260318033143.htm https://www.sciencedaily.com/releases/2026/03/260315225121.htm A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. Mon, 16 Mar 2026 20:18:42 EDT https://www.sciencedaily.com/releases/2026/03/260315225121.htm https://www.sciencedaily.com/releases/2026/03/260309225222.htm Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people with bladder cancer who are also colorblind have a 52% higher mortality rate over 20 years compared to those with normal vision. The likely reason: many people with color vision deficiency struggle to see red, making it harder to notice blood in urine, the most common early sign of bladder cancer. Tue, 10 Mar 2026 01:49:43 EDT https://www.sciencedaily.com/releases/2026/03/260309225222.htm https://www.sciencedaily.com/releases/2026/03/260305223240.htm A Rutgers-led study found that eating less protein may help slow liver cancer in people with impaired liver function. When damaged livers can’t properly clear toxic ammonia from protein metabolism, the excess ammonia can feed tumor growth. In mice, reducing dietary protein lowered ammonia levels, slowed tumor growth, and significantly improved survival. Fri, 06 Mar 2026 05:17:57 EST https://www.sciencedaily.com/releases/2026/03/260305223240.htm https://www.sciencedaily.com/releases/2026/03/260303050624.htm Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control. Tue, 03 Mar 2026 11:33:04 EST https://www.sciencedaily.com/releases/2026/03/260303050624.htm https://www.sciencedaily.com/releases/2026/02/260228093456.htm Scientists at Oregon State University have engineered a powerful new nanomaterial that zeroes in on cancer cells and destroys them from the inside out. Designed to exploit cancer’s unique chemistry—its acidity and high hydrogen peroxide levels—the tiny iron-based structure sparks not one but two intense chemical reactions, flooding tumors with cell-damaging oxygen molecules. This dual attack overwhelms cancer cells with oxidative stress while sparing healthy tissue. Sun, 01 Mar 2026 09:09:30 EST https://www.sciencedaily.com/releases/2026/02/260228093456.htm https://www.sciencedaily.com/releases/2026/02/260224023101.htm Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they’re the perfect breeding ground for these microbes. The team added a genetic tweak that helps the bacteria survive longer near oxygen-exposed edges — but only once enough of them are present to trigger the change. It’s a carefully programmed biological attack that could one day offer a new way to destroy cancer. Tue, 24 Feb 2026 03:41:46 EST https://www.sciencedaily.com/releases/2026/02/260224023101.htm https://www.sciencedaily.com/releases/2026/02/260216084527.htm A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that identify cancer type and subtype with remarkable accuracy. Some even drive tumor growth and metastasis. Because many are released into the bloodstream, a simple blood test can track how patients respond to treatment and predict survival. Tue, 17 Feb 2026 03:50:37 EST https://www.sciencedaily.com/releases/2026/02/260216084527.htm https://www.sciencedaily.com/releases/2026/02/260216044006.htm Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components. Wed, 18 Feb 2026 10:00:32 EST https://www.sciencedaily.com/releases/2026/02/260216044006.htm https://www.sciencedaily.com/releases/2026/02/260212234216.htm Fish oil’s cancer-fighting reputation may hinge on a little-known gene. Researchers discovered that omega-3s like EPA and DHA help curb colorectal cancer only when the enzyme ALOX15 is present. Without it, fish oil sometimes increased tumor growth in mice—especially DHA. The results suggest that not all supplements work the same way, and genetics could determine who truly benefits. Fri, 13 Feb 2026 09:20:25 EST https://www.sciencedaily.com/releases/2026/02/260212234216.htm https://www.sciencedaily.com/releases/2026/02/260210040604.htm Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against infection—can be reprogrammed inside tumors to fuel cancer growth instead. Once exposed to the tumor environment, these immune cells begin producing a molecule called CCL3 that actively promotes tumor progression. Tue, 10 Feb 2026 10:28:42 EST https://www.sciencedaily.com/releases/2026/02/260210040604.htm https://www.sciencedaily.com/releases/2026/02/260206012229.htm Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells aren’t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these “good” and “bad” cells can determine whether a tumor grows or shrinks. Fri, 06 Feb 2026 11:03:34 EST https://www.sciencedaily.com/releases/2026/02/260206012229.htm https://www.sciencedaily.com/releases/2026/02/260204121540.htm Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that some changes barely boost cancer signals, while others supercharge them. When matched against real patient data, the map accurately predicted cancer behavior across tissues. Thu, 05 Feb 2026 07:29:14 EST https://www.sciencedaily.com/releases/2026/02/260204121540.htm https://www.sciencedaily.com/releases/2026/01/260129080432.htm Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form metastases. This process also creates a tough, fibrous barrier that makes treatments less effective. Targeting periostin could help stop this invasion before it starts. Fri, 30 Jan 2026 07:44:14 EST https://www.sciencedaily.com/releases/2026/01/260129080432.htm https://www.sciencedaily.com/releases/2026/01/260128075350.htm Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor can be seen. IDH-mutant glioma, long treated by removing visible tumor tissue, actually starts when normal-looking brain cells quietly acquire a cancer-linked mutation and spread through the brain’s cortex. Using advanced genetic mapping and animal models, researchers traced the cancer’s true origin to glial progenitor cells that appear healthy at first. Wed, 28 Jan 2026 07:53:50 EST https://www.sciencedaily.com/releases/2026/01/260128075350.htm https://www.sciencedaily.com/releases/2026/01/260128075332.htm Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against it. Instead of attacking cancer cells head-on, the experimental immunotherapy targets macrophages—immune cells that tumors hijack to shield themselves from attack. By eliminating or reprogramming these “bodyguards,” the treatment cracks open the tumor’s protective barrier and allows the immune system to flood in and destroy the cancer. Fri, 30 Jan 2026 01:05:29 EST https://www.sciencedaily.com/releases/2026/01/260128075332.htm https://www.sciencedaily.com/releases/2026/01/260127112137.htm Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body. Tumors are packed with macrophages, immune cells that should attack cancer but are usually silenced by the tumor environment. By injecting a specially designed drug directly into tumors, researchers were able to “reprogram” these dormant cells to recognize and destroy cancer. Wed, 28 Jan 2026 09:57:00 EST https://www.sciencedaily.com/releases/2026/01/260127112137.htm https://www.sciencedaily.com/releases/2026/01/260125083344.htm Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that help tumors grow, adapt, and survive treatment. By tracking thousands of individual cells over time, the approach shows which chromosome combinations give cancer an edge and why some tumors become especially resilient. Mon, 26 Jan 2026 04:41:20 EST https://www.sciencedaily.com/releases/2026/01/260125083344.htm https://www.sciencedaily.com/releases/2026/01/260124003811.htm Pancreatic cancer may evade the immune system using a clever molecular trick. Researchers found that the cancer-driving protein MYC also suppresses immune alarm signals, allowing tumors to grow unnoticed. When this immune-shielding ability was disabled in animal models, tumors rapidly collapsed. The findings point to a new way to expose cancer to the body’s own defenses without harming healthy cells. Sat, 24 Jan 2026 00:38:11 EST https://www.sciencedaily.com/releases/2026/01/260124003811.htm https://www.sciencedaily.com/releases/2026/01/260122074030.htm Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor growth and shuts down immune defenses, effectively turning the immune system back on. In early tests, the treatment slowed tumor growth, reduced lung metastases, and destroyed chemotherapy-resistant cancer cells. Thu, 22 Jan 2026 23:43:30 EST https://www.sciencedaily.com/releases/2026/01/260122074030.htm https://www.sciencedaily.com/releases/2026/01/260120000323.htm Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. Tue, 20 Jan 2026 03:47:11 EST https://www.sciencedaily.com/releases/2026/01/260120000323.htm https://www.sciencedaily.com/releases/2026/01/260115022808.htm A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies. Fri, 16 Jan 2026 06:06:55 EST https://www.sciencedaily.com/releases/2026/01/260115022808.htm https://www.sciencedaily.com/releases/2026/01/260114084129.htm Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat. Northwestern scientists discovered this hidden mechanism and created an antibody that strips away the tumor’s protective signal. In animal tests, immune cells sprang back into action and tumors grew much more slowly. The team is now refining the therapy for future human trials. Thu, 15 Jan 2026 02:10:05 EST https://www.sciencedaily.com/releases/2026/01/260114084129.htm https://www.sciencedaily.com/releases/2026/01/260110211207.htm KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug injected directly into the tumor is absorbed by macrophages, prompting them to recognize and attack cancer cells while activating nearby immune defenses. This eliminates the need for lab-based cell extraction and modification. In animal models, the strategy significantly slowed tumor growth and sparked strong anticancer immune responses. Sun, 11 Jan 2026 06:11:54 EST https://www.sciencedaily.com/releases/2026/01/260110211207.htm https://www.sciencedaily.com/releases/2025/12/251222044058.htm Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors use to stay invisible to immune defenses—special sugar molecules on the cancer cell surface that suppress immune activity. Early tests show it can supercharge immune responses and outperform current antibody therapies. Tue, 23 Dec 2025 08:54:27 EST https://www.sciencedaily.com/releases/2025/12/251222044058.htm https://www.sciencedaily.com/releases/2025/12/251209043050.htm New research is challenging one of medicine’s oldest assumptions: that cancer must be attacked to be cured. By treating glioblastoma patients with a simple combination of resveratrol and copper, the researchers found dramatic reductions in tumor aggressiveness, cancer biomarkers, immune checkpoints, and stem-cell–related markers—all without side effects. Their approach focuses on “healing” tumors by eliminating harmful cell-free chromatin particles released from dying cancer cells, which normally inflame and worsen the disease. The findings hint at a future where inexpensive nutraceuticals could transform cancer therapy. Wed, 10 Dec 2025 03:56:21 EST https://www.sciencedaily.com/releases/2025/12/251209043050.htm https://www.sciencedaily.com/releases/2025/11/251124094314.htm Scientists are uncovering what makes some carcinomas so resistant: their ability to change identity. Two new studies reveal crucial proteins and structures that could become targets for future therapies. These discoveries deepen understanding of how tumors reprogram themselves and point toward highly specific treatments. The work raises hopes for safer, more selective cancer drugs. Mon, 24 Nov 2025 10:26:21 EST https://www.sciencedaily.com/releases/2025/11/251124094314.htm https://www.sciencedaily.com/releases/2025/11/251122044329.htm A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with drugs that boost T-cell activity, the treatment eliminated tumors in mice and built long-lasting immunity. The results suggest a powerful new direction for brain cancer immunotherapy. Sat, 22 Nov 2025 12:24:13 EST https://www.sciencedaily.com/releases/2025/11/251122044329.htm https://www.sciencedaily.com/releases/2025/11/251120002828.htm Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a particular molecular signal to weaken T cells, and that interrupting this signal helps the cells stay active. Thu, 20 Nov 2025 00:28:28 EST https://www.sciencedaily.com/releases/2025/11/251120002828.htm https://www.sciencedaily.com/releases/2025/11/251120002606.htm Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, with many cancer cells essentially triggering their own self-destruct mode. The work points to a fresh strategy for targeting stubborn lung cancers. Thu, 20 Nov 2025 00:26:06 EST https://www.sciencedaily.com/releases/2025/11/251120002606.htm https://www.sciencedaily.com/releases/2025/11/251117095637.htm Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were edited, making it practical for real-world treatment. Since NRF2 fuels resistance in several cancers, the approach could have broad impact. Mon, 17 Nov 2025 10:40:18 EST https://www.sciencedaily.com/releases/2025/11/251117095637.htm https://www.sciencedaily.com/releases/2025/11/251111010000.htm TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional short-term treatments. The therapy may replace bladder removal surgery for many and has earned FDA Priority Review due to its impressive results. Tue, 11 Nov 2025 01:00:00 EST https://www.sciencedaily.com/releases/2025/11/251111010000.htm https://www.sciencedaily.com/releases/2025/10/251017081515.htm Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that suppress T cells and found that supplementing with UDCA reversed the effect, controlling tumor growth in mice. Since UDCA is already used for liver disease, it could quickly translate into clinical trials. Fri, 17 Oct 2025 08:37:08 EDT https://www.sciencedaily.com/releases/2025/10/251017081515.htm https://www.sciencedaily.com/releases/2025/10/251015230959.htm Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune structures inside tumors that improved survival and prevented recurrence. This approach could make existing immunotherapies and chemotherapies more effective and long-lasting. Wed, 15 Oct 2025 23:09:59 EDT https://www.sciencedaily.com/releases/2025/10/251015230959.htm https://www.sciencedaily.com/releases/2025/10/251013040323.htm UMass Amherst researchers have developed a groundbreaking nanoparticle-based cancer vaccine that prevented melanoma, pancreatic, and triple-negative breast cancers in mice—with up to 88% remaining tumor-free. The vaccine triggers a multi-pathway immune response, producing powerful T-cell activation and long-term immune memory that stops both tumor growth and metastasis. By combining cancer-specific antigens with a lipid nanoparticle “super adjuvant,” it overcomes key challenges in cancer immunotherapy. Mon, 13 Oct 2025 04:03:23 EDT https://www.sciencedaily.com/releases/2025/10/251013040323.htm https://www.sciencedaily.com/releases/2025/10/251007081835.htm Scientists have discovered that bacteria living inside tumors can produce a molecule that fights cancer and enhances chemotherapy. The molecule, called 2-methylisocitrate (2-MiCit), was found to make colorectal cancer cells more vulnerable to chemotherapy by damaging their DNA and disrupting their metabolism. Experiments using worms, flies, and human cancer cells confirmed its potent anti-cancer effects. Tue, 07 Oct 2025 08:18:35 EDT https://www.sciencedaily.com/releases/2025/10/251007081835.htm https://www.sciencedaily.com/releases/2025/09/250916221917.htm Rogue DNA rings known as ecDNA may hold the key to cracking glioblastoma’s deadly resilience. Emerging before tumors even form, they could offer scientists a crucial early-warning system and a chance to intervene before the disease becomes untreatable. Wed, 17 Sep 2025 21:33:46 EDT https://www.sciencedaily.com/releases/2025/09/250916221917.htm https://www.sciencedaily.com/releases/2025/09/250910000314.htm New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial tested immunotherapy in resectable cases, with promising results presented at the World Conference on Lung Cancer. Thu, 11 Sep 2025 07:04:48 EDT https://www.sciencedaily.com/releases/2025/09/250910000314.htm https://www.sciencedaily.com/releases/2025/09/250910000307.htm Glioblastoma’s stealthy spread has met a new challenge: MRI-powered fluid flow mapping that reveals where the cancer is likely to invade next. The innovation is now being advanced by a spinoff company to guide personalized cancer treatments. Wed, 10 Sep 2025 21:24:04 EDT https://www.sciencedaily.com/releases/2025/09/250910000307.htm https://www.sciencedaily.com/releases/2025/09/250902085143.htm Scientists at the University of Pennsylvania have shown for the first time that it’s possible to detect dormant cancer cells in breast cancer survivors and eliminate them with repurposed drugs, potentially preventing recurrence. In a clinical trial, existing medications cleared these hidden cells in most participants, leading to survival rates above 90%. The findings open a new era of proactive treatment against breast cancer’s lingering threat, offering hope to survivors haunted by the fear of relapse. Tue, 02 Sep 2025 08:51:43 EDT https://www.sciencedaily.com/releases/2025/09/250902085143.htm https://www.sciencedaily.com/releases/2025/08/250820000752.htm Scientists have uncovered a hidden weakness in one of the deadliest childhood cancers. The tumors, which spread quickly and are notoriously hard to treat, rely on a sugar-processing pathway to survive and grow. By blocking this pathway, researchers were able to slow down the cancer and make it more vulnerable to treatment. This breakthrough opens the door to new therapies for children and young adults facing a disease with very few options today. Wed, 20 Aug 2025 00:07:52 EDT https://www.sciencedaily.com/releases/2025/08/250820000752.htm https://www.sciencedaily.com/releases/2025/08/250818102951.htm A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers. Unlike traditional vaccines designed to target specific tumor proteins, this approach simply revs up the immune system as if it were fighting a virus. The results were dramatic—when paired with checkpoint inhibitors, tumors shrank, and in some cases, the vaccine alone wiped them out. Tue, 19 Aug 2025 02:22:25 EDT https://www.sciencedaily.com/releases/2025/08/250818102951.htm https://www.sciencedaily.com/releases/2025/08/250816113522.htm Scientists have engineered a groundbreaking cancer treatment that uses bacteria to smuggle viruses directly into tumors, bypassing the immune system and delivering a powerful one-two punch against cancer cells. The bacteria act like Trojan horses, carrying viral payloads to cancer’s core, where the virus can spread and destroy malignant cells. Built-in safety features ensure the virus can’t multiply outside the tumor, offering a promising pathway for safe, targeted therapy. Sun, 17 Aug 2025 10:28:53 EDT https://www.sciencedaily.com/releases/2025/08/250816113522.htm https://www.sciencedaily.com/releases/2025/08/250805041619.htm Pancreatic cancer cells are known for being hard to treat, partly because they change the environment around them to block drugs and immune cells. Scientists discovered that these tumors use a scavenging process—called macropinocytosis—to pull nutrients from nearby tissue and keep growing. By blocking this process in mice, researchers were able to change the tumor’s environment, making it softer, less dense, and easier for immune cells and therapies to reach. Tue, 05 Aug 2025 23:17:12 EDT https://www.sciencedaily.com/releases/2025/08/250805041619.htm https://www.sciencedaily.com/releases/2025/08/250803233100.htm Head and neck cancer, notoriously hard to treat, might have a new weakness—timing. Researchers discovered that syncing radiation and immunotherapy in just the right way can make tumors disappear in mice. By protecting the body’s immune system hubs, they’ve unlocked a potentially powerful method to fight aggressive cancers more effectively. Clinical trials are already underway, hinting at a new era in cancer treatment. Mon, 04 Aug 2025 00:35:24 EDT https://www.sciencedaily.com/releases/2025/08/250803233100.htm https://www.sciencedaily.com/releases/2025/08/250803011826.htm Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more effective. By combining this novel method with cisplatin, researchers reversed harmful tumor metabolism and empowered immune cells to fight back, all without added toxicity. Sun, 03 Aug 2025 04:12:15 EDT https://www.sciencedaily.com/releases/2025/08/250803011826.htm https://www.sciencedaily.com/releases/2025/07/250730030352.htm A group of Australian scientists has uncovered a new way to fight some of the toughest cancers by targeting an overlooked cellular process called minor splicing. This tiny but vital mechanism turns out to be essential for the growth of certain tumors, especially those driven by KRAS mutations — a common but hard-to-treat culprit in cancer. By blocking minor splicing, researchers triggered DNA damage and activated the body’s own cancer-defense system, killing cancer cells while sparing healthy ones. The results in animal and human cell models are so promising that drug development is now underway, potentially paving the way for more effective and less toxic treatments across multiple cancer types. Wed, 30 Jul 2025 08:30:40 EDT https://www.sciencedaily.com/releases/2025/07/250730030352.htm https://www.sciencedaily.com/releases/2025/07/250724232403.htm A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, the cowpea mosaic virus (CPMV) can awaken the human immune system and transform it into a cancer-fighting powerhouse, without infecting human cells. By comparing it to a similar, but ineffective, virus, researchers uncovered that CPMV uniquely triggers potent interferons and immune responses, making it a low-cost, plant-grown immunotherapy on the fast track toward clinical trials. Fri, 25 Jul 2025 05:07:43 EDT https://www.sciencedaily.com/releases/2025/07/250724232403.htm https://www.sciencedaily.com/releases/2025/07/250723045702.htm Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with immunotherapy can transform stubborn, unresponsive lung tumors into targets for immune attack—especially those considered “cold” and typically resistant. This happens through a rare and poorly understood effect where immune cells are activated systemically, not just at the radiation site. Patients whose tumors underwent this “warm-up” had significantly better outcomes, revealing a promising new strategy for fighting hard-to-treat cancers. Wed, 23 Jul 2025 09:33:19 EDT https://www.sciencedaily.com/releases/2025/07/250723045702.htm https://www.sciencedaily.com/releases/2025/07/250702214136.htm Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers than our primate cousins. The change affects a protein used by immune cells to kill tumors—except in humans, it’s vulnerable to being shut down by an enzyme that tumors release. This flaw may be one reason treatments like CAR-T don’t work as well on solid tumors. The surprising twist? That mutation might have helped our brains grow larger over time. Now, researchers are exploring ways to block the enzyme and give our immune system its power back. Wed, 02 Jul 2025 23:14:53 EDT https://www.sciencedaily.com/releases/2025/07/250702214136.htm https://www.sciencedaily.com/releases/2025/06/250630073440.htm An AI system called iSeg is reshaping radiation oncology by automatically outlining lung tumors in 3D as they shift with each breath. Trained on scans from nine hospitals, the tool matched expert clinicians, flagged cancer zones some missed, and could speed up treatment planning while reducing deadly oversights. Mon, 30 Jun 2025 09:05:57 EDT https://www.sciencedaily.com/releases/2025/06/250630073440.htm https://www.sciencedaily.com/releases/2025/06/250625012445.htm A new AI tool, AAnet, has discovered five distinct cell types within tumors, offering a deeper look into cancer's inner diversity. This insight could transform how we treat cancer, enabling more personalized therapies that tackle every type of cell in a tumor. Wed, 25 Jun 2025 07:39:07 EDT https://www.sciencedaily.com/releases/2025/06/250625012445.htm https://www.sciencedaily.com/releases/2025/06/250609060137.htm A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which deliver electric waves into tumors, with immunotherapy and chemotherapy, researchers saw a major boost in survival. Mon, 09 Jun 2025 06:01:37 EDT https://www.sciencedaily.com/releases/2025/06/250609060137.htm https://www.sciencedaily.com/releases/2025/06/250602225406.htm Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer. Mon, 02 Jun 2025 22:54:06 EDT https://www.sciencedaily.com/releases/2025/06/250602225406.htm